Therefore, one could hypothesize that the superior effect of PLX3397 on tumor growth inhibition could at least in part be related to superior inhibition of M-CSF signaling and consequent TAM attenuation, acting synergistically to the Kit inhibition. Here, KIT is linked to neoplasm.